To further define if the NLRP3 inflammasome signaling drives Aβ accumulation and AD pathology after HSV-1 infection, we administrated MCC950 sodium, a selective small-molecular inhibitor of the NLRP3 inflammasome, to inhibit inflammasome activation [59, 60]. This evidence concerns the gene NLRP3 and Alzheimer disease.